Myocardial microRNAs associated with reverse remodeling in human heart failure

Area of Science:

• Cardiology
• Molecular Biology
• Genetics

Background:

• Dilated cardiomyopathies (DCMs) involve genetic changes affecting heart function.
• MicroRNAs (miRs) are known regulators of gene expression and cardiac remodeling.

Purpose of the Study:

• To investigate if dynamic changes in myocardial miR expression predict reverse remodeling in DCM patients treated with beta-blockers.
• To identify specific miRs involved in the response to beta-blocker therapy.

Main Methods:

• Forty-three idiopathic DCM patients received beta-blocker treatment.
• Serial cardiac function assessments and endomyocardial biopsies were performed.
• RT-PCR and array-based methods measured miR expression changes; pathway analysis (PA) was conducted.

Main Results:

• At 3 months, decreased miR-208a-3p and miR-591 levels correlated with reverse remodeling and predicted reduced apoptosis.
• At 12 months, altered levels of five miRs (including miR-208a-3p, miR-208b-3p, miR-21-5p, miR-199a-5p, and miR-1-3p) were observed in responders.
• Pathway analysis indicated these miRs predicted improved cardiac function and reduced adverse remodeling.

Conclusions:

• Myocardial miRs serve as predictive biomarkers for beta-blocker-induced reverse remodeling in DCM.
• Specific miRs identified likely play a regulatory role in the myocardial remodeling process.